TANDEM TRIAL: a factorial randomised controlled trial of dose and review schedule of bevacizumab (Avastin) for neovascular macular degeneration in the East Midlands
暂无分享,去创建一个
A. Foss | A. Montgomery | L. Duley | R. Ogollah | E. Mitchell | M. Childs | Rebecca Haydock | S. Dhar-munshi | T. Empeslidis | M. Ozolins | P. Tesha